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ABSTRACT Recent observations in cell culture provide evidence that negatively charged glycosaminoglycans (GAGs) at the
surface of biological cells bind cationic cell-penetrating compounds (CPCs) and cluster during CPC binding, thereby contributing to
their endocytotic uptake. The GAG binding and clustering occur in the low-micromolar concentration range and suggest a tight
interaction between GAGs and CPCs, although the relation between binding afﬁnity and speciﬁcity of this interaction remains to be
investigated. We therefore measured the GAG binding and clustering of various mono- and multivalent CPCs such as DNA
transfection vectors (polyethylenimine; 1,2-dioleoyl-3-trimethylammonium-propane), amino acid homopolymers (oligoarginine;
oligolysine), and cell-penetrating peptides (Penetratin; HIV-1 Tat) by means of isothermal titration calorimetry and dynamic light
scattering. We ﬁnd that these structurally diverse CPCs share the property of GAG binding and clustering. The binding is very tight
(microscopic dissociation constants between 0.34 and 1.34 mM) and thus biologically relevant. The hydrodynamic radius of the
resulting aggregates ranges from 78 nm to 586 nm, suggesting that they consist of numerous GAG chains cross-linked by CPCs.
Likewise, the membrane-permeant monovalent cation acridine orange leads to GAG binding and clustering, in contrast to its
membrane-impermeant structural analogs propidium iodide and ethidium bromide. Because the binding and clustering of GAGs
were found to be a common denominator of all CPCs tested, these properties might be helpful to identify further CPCs.
INTRODUCTION
The membrane of biological cells basically controls the in-
ﬂux and efﬂux of molecules. The manipulation of this barrier
in biology and medicine with the intention either to promote
the permeability, as for drug and gene therapy, or to inhibit
the cellular uptake, as during viral infections, is therefore
highly relevant. In this respect, cell-penetrating peptides
(CPPs) have proven to be very efﬁcient molecules because
they cross intact cell membranes within seconds to minutes
by amechanism that is poorly understood (reviewed byRichard
et al. (1)).
These molecules are of general interest because they can
also facilitate the import of covalently and noncovalently
bound drugs, genes, and macromolecules that would not
otherwise cross the membrane. Their uptake mechanism
proper, however, is controversial because of technical arti-
facts, limitations of model membranes employed, and non-
comparable experimental approaches (1). CPPs have quite
different chemical structures, but they share a high cationic
charge density (Fig. 1), which rules out their passive per-
meation through the lipid membrane.
As an important primary step of CPP uptake, it has recently
been observed in living cells that the CPP HIV-1 Tat-PTD
leads to the clustering of cell-surface-bound molecules co-
inciding with the rapid uptake of this CPP into the cell plasma
(2). Similarly, a clustering of cell-surface-bound molecules
was observed during DNA transfection with the nonpeptidic
cell-penetrating compound (CPC) polyethylenimine (3) and
cationic lipofectants (4,5). Related in vivo studies suggest
that cross-linking of glycosaminoglycan (GAG)-containing
proteins is likely an important mediator of the cellular CPP
uptake (6–12). This assumption is further substantiated by
the observation that enzymatic or genetic removal of GAGs
from the surface of living cells reduces or abolishes the up-
take of CPPs in vivo (2,12–14). In analogy to such in vivo
observations, GAG binding and clustering have recently
been substantiated in vitro for the interaction of Tat with
heparan sulfate (15).
Our study aimed at investigating the question of whether
further CPCs share the property of GAG binding and, in
particular, GAG clustering. Furthermore, knowledge of re-
lated thermodynamic binding parameters is decisive to un-
derstand the delicate balance among the optimum molar ratio
of cargo and CPC, extracellular stability of this uptake com-
plex, and intracellular release of the cargo (16).
We investigated various mono- and polycationic CPCs
with respect to their properties of GAG binding and clus-
tering in vitro. Clustering is of particular importance in recent
discussions of adsorptive endocytosis (6). The CPCs are all
known to pass the membrane of intact cells but differ con-
siderably in their primary structure, valency, amine type, and
pKa (Fig. 1). The monovalent cation acridine orange was also
included in our investigation because of its structural analogy
to propidium iodide and ethidium bromide, molecules that
are both excluded from living cells (17). In contrast, acridine
orange is taken up by living cells (18). In analogy to CPCs, its
elevated pKa (19), the energy dependence of its in vivo up-
take (20), the need of active loading procedures for inclusion
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into membrane vesicles (21), and the limited membrane dif-
fusion (22) all make passive diffusion across the membrane
unlikely as an uptake mechanism. Heparin was selected as
GAG because heparin-like N-sulfo domains provide ligand
recognition in cell-surface-associated heparan sulfate (23).
METHODS
Material
Porcine intestinal mucosa heparin (sodium salt; sulfate content of 11.3%;
average mol wt 13,000) was from Celsus Laboratories (Cincinnati, OH). L-a-
dioleoyl-phosphatidylcholine (DOPC) and 1,2-dioleoyl-3-trimethylammo-
nium-propane (DOTAP) were obtained from Avanti Polar Lipids (Alabaster,
AL). These lipids were used to produce small unilamellar vesicles by soni-
cation. Linear polyethylenimine (LPEI) (mol wt 2500) was purchased from
Polysciencences (Eppelheim, Germany), and all other chemicals of HPLC
grade were from Sigma-Aldrich (Buchs, Switzerland).
Peptide synthesis
Solid-phase peptide synthesis of HIV Tat-PTD, penetratin, nona-L-arginine,
and hexadeca-L-lysine was performed on an Abimed EPS221 peptide syn-
thesizer (Langenfeld, Germany) using Fmoc-protected amino acids and
preloaded NovaSyn TGA resins. After synthesis, the peptides were puriﬁed
by preparative high-pressure liquid chromatography. The mass of the pep-
tides was conﬁrmed by electrospray ionization mass spectrometry, and
peptide purity (.98%) was measured by analytical high-pressure liquid
chromatography. The effective peptide concentration was measured as
amino acid content after acid hydrolysis.
Isothermal titration calorimetry
The heat ﬂow resulting from the binding of CPCs to heparin was measured
with high-sensitivity isothermal titration calorimetry using a MicroCal
Omega and VP-ITC calorimeter (Northampton, MA) with a reaction cell
volume of 1.4 ml. The ITC data were evaluated according to the multisite
binding model (24):
½L
b
½GAG
t
¼ n3Ki½L
11Ki½L; (1)
where [L]b and [L] are the concentrations of bound and free ligand, respec-
tively, [GAG]t is the total concentration of the GAG, Ki is the microscopic
binding constant to each individual binding site in the GAG, and n are the
number of ligands bound per GAG molecule. Ki, n, and the ligand binding
enthalpy, DH0L; may be directly determined by a three-parameter least-
squares ﬁt to the calorimetric data because the heat released in injection i,
dQi, is proportional to the concentration of bound ligand per injection by
dQi ¼ DH0L3 d½Lb;i3V; (2)
where d[L]b,i is the change in bound ligand concentration upon injection i,
and V is the actual reaction volume. For a macromolecule with n independent
binding sites, the binding constant of the individual binding site varies with
the degree of saturation for statistical reasons (24), with the ﬁrst ligand
binding with the macroscopic binding constant K1 ¼ nKi, and the last with
Kn ¼ Ki/n. For better comparison with literature, dissociation constants Kd
are reported that are just the inverse of the binding constants.
Static right-angle light scattering
Static light scattering at a right angle was measured with a Jasco FP 777
ﬂuorimeter (Tokyo, Japan) at a wavelength of 350 nm under constant stirring
and at a temperature of 28C. Quartz cuvettes with inner lengths of 1 cmwere
ﬁlled with 1.4 ml of heparin solution, and 10-ml aliquots of the ligand so-
lution were added at 5-min intervals.
Dynamic light scattering
Dynamic light scattering (DLS) experiments were performed on an ALV/
CGS-5022F instrument (ALV, Langen, Germany) equipped with a HeNe
laser (l ¼ 632.8 nm) and an ALV-5000/EPP multi-tau digital correlator.
Reactant solutions were ﬁltered (0.22 mm; Millipore, Billerica, MA) before
mixing. Measurements were performed in 1 cm (outer diameter) cylindrical
cuvettes at 20C using eight different scattering angles u (30–150). The
normalized intensity autocorrelation functions were analyzed using a second-
order cumulant analysis (25) yielding the collective diffusion coefﬁcient D.
The latter was used to calculate the hydrodynamic radius (Rh) using the
Stokes-Einstein relationship Rh ¼ kT/6phD, where k is the Boltzmann’s
constant, T the absolute temperature, and h the viscosity of water. The re-
ported Rh was obtained by extrapolating Rh of eight different angles to zero
scattering angle. The width of the Rh distribution was calculated as full width
at half-maximum by means of the diffusion coefﬁcient distribution (25).
To estimate the maximum number of heparin chains within a CPC-GAG
cluster, the hydrodynamic volume of the cluster was assumed to be of
FIGURE 1 Structures of the compounds investigated. CPCs are classiﬁed
mainly on the basis of their historical discovery and/or intended use or
application. The classes comprise (1, 2) amino acid homopolymers, (3) DNA
transfection agents, (4) cationic lipids, and (7, 8) CPPs. Individual structures
are (1) nona-L-arginine, (2) hexadeca-L-lysine (PLL16), (3) linear polyethyl-
enimine (LPEI), (4) 1,2-dioleoyl-3-trimethylammonium-propane (DOTAP),
(5) cell-permeant acridine orange (AOR), (6) cell-impermeant propidium
iodide, (7) HIV-1 Tat(47–57), and (8) penetratin. Not shown are monomeric
L-arginine and cell-impermeant ethidium bromide (similar to 6). Charges at
physiological pH were assigned on the basis of literature values of the pKa.
These were 12.5, 10.3,;7, and 10.2 for 1, 2, 3, and 5, respectively (19,54).
Glycosaminoglycan Binding and Clustering 2143
Biophysical Journal 94(6) 2142–2149
spherical shape (Vh ¼ 4=3pR3h) and was divided by the volume of a single
heparin chain saturated with the deﬁned number of ligands as measured by
ITC. The volume of the individual molecules was calculated from known
protein database entries as the Connolly solvent-excluded volume (26) using
the software Chem3D Pro (Cambridge, MA).
RESULTS AND DISCUSSION
Binding afﬁnity
Despite the considerable difference in their overall structures
(Fig. 1), all CPCs were found to bind the GAG with a high
afﬁnity (Fig. 2) characterized by a distinct number of binding
sites and a dissociation constant of the individual binding site
in the submicromolar range (Table 1). The observed afﬁnity
for GAGs is thus biologically relevant because the CPP
concentration generally required for efﬁcient cell penetration
(1–10 mM) and physiological GAG concentration are of
similar magnitude. For ﬁbroblasts, for example, 2 mg of
sulfated GAGs/mg dry tissue are reported (27), correspond-
ing to a macroscopic GAG concentration of ;7 mM using a
typical molecular weight of GAGs found in ﬁbroblasts (28)
and an average tissue water content. The effective concen-
tration of individual binding sites is even higher because each
GAG can bind several CPPs (Table 1). Compared with CPP
binding to GAGs of low sulfate content or short chain length
(15,29), the current data indicate an up to fourfold higher
binding afﬁnity, supporting earlier observations that both
chain length and sulfate content of GAGs inﬂuence the
binding afﬁnity in the interaction with CPPs (30).
Compared with the interaction of protein-based cell re-
ceptors with growth factors or cytokines, which usually bind
in the low-nanomolar range, present dissociation constants in
the high-nanomolar range presumably facilitate the release
of the CPC after internalization of the binding site. Accord-
ingly, the intracellular release and redistribution of CPCs to
the nucleus are commonly observed after the CPC uptake
(2,31), suggesting a tighter interaction of CPCs with intra-
cellular compounds such as DNA (16).
Interestingly, the cationic DNA dyes ethidium bromide
and propidium iodide do not bind the GAG at physiological
ionic strength and low-micromolar concentration (Fig. 2,
Table 1). For instance, ethidium bromide was reported to
bind heparin in pure water (Kd  0.6 M), but not at physio-
logical ionic strength (32). In contrast, acridine orange binds
with Kd 0.87mM (Table 1) (33), although all three dyes are
known to bind DNA with high afﬁnity (34). This remarkable
difference and their different optical properties on polyelec-
trolyte binding (35) suggest that the binding of these cationic
dyes to different polyanions follows different mechanisms. It
is thus of future interest to clarify whether the pronounced
difference in GAG binding is also the basis of their different
biological uptake behavior, i.e., no membrane passage for
ethidium and propidium (17) but rapid uptake and accumu-
lation of acridine orange in endosomes (18,36).
Binding mechanism
At 28C, the GAG binding was exothermic for all CPCs (Fig.
1). A negative enthalpy change makes the major contribution
to the free energy change for most CPCs (Table 1). For hy-
drophobic CPCs, such as DOTAP and acridine orange
(AOR), however, the reaction entropy provided the main
binding force. This is most likely the consequence of the
release of hydration water, which is further supported by the
observed negative molar heat capacity change (see below).
Interestingly, the cationic charge alone is not sufﬁcient to
provide CPC binding to GAGs because a tight binding was
FIGURE 2 All CPCs investigated bind the sulfated GAG heparin. Isother-
mal titration calorimetry of various cell-impermeant (A and B) and -permeant
compounds (C and D) with heparin. (A–C) Heat ﬂow (same y axis for all three
panels). Every 10 min, 5 ml of 15 mM heparin is titrated into the reaction cell
(Vcell ¼ 1.4 ml) ﬁlled with (A) 100 mM propidium iodide, (B) 100 mM
ethidium bromide, or (C) 100 mM acridine orange. (D) Heats of reaction hi
(equal to integration of the heat ﬂow peaks) as a function of the number of
injections Ni. The heparin concentration in the reaction cell (Vcell ¼ 1.4 ml) is
13.7 mM. Each symbol corresponds to the injection (10 ml every 10 min) of
the following compounds: (s) 10.4 mM L-arginine, (d) DOTAP vesicles
([DOTAP]out ¼ 4.8 mM, 30 nm, DOTAP:DOPC ¼ 3:7 (n/n)), ()) 650 mM
PLL16, (:) 717 mM LPEI, (w) 1.167 mM nona-L-arginine, (h) 1.302 mM
HIV Tat-PTD, and (n) 1.486 mM penetratin. Symbols represent experimental
data. The solid line is a least-squares ﬁt using the binding model described by
Eqs. 1 and 2 with the parameters listed in Table 1. Temperature is 28C. Buffer
in all experiments is 30 mM phosphate and 77 mM NaCl at pH 7.40 with a
resulting physiological ionic strength of 154 mM.
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found for nona-arginine but not for its monomer arginine
compared at identical arginine monomer concentrations
(Fig. 2). This suggests that electrostatic interactions at low-
micromolar concentrations require a minimum charge density
as corroborated by the polyelectrolyte theory (37).
The change in the molar heat capacity DC0P provides a
good approximation to distinguish between electrostatic and
hydrophobic contribution to the binding. Generally, a nega-
tive DC0P indicates a change in the solvent-accessible surface
area (hydrophobic effect) (38), in contrast to a positive heat
capacity, which often indicates the dominance of electrostatic
interactions (39).
We ﬁnd that the highly charged CPCs nona-arginine and
HIV-1 Tat-PTD bind the GAG with a positive DC0P; indi-
cating that GAG binding is driven mainly by electrostatic
forces. However, the amplitude of DC0P is lower than expected
for a pure electrostatic interaction, suggesting additional hy-
drogen bonds in the binding reaction through interactions of
guanidinium groups with sulfates and carboxylates (40–42).
In contrast, the amphipathic CPCs AOR and DOTAP
display a negative DC0P; indicating that GAG binding and
aggregation are dominated by the decrease in the water-
accessible surface area. This change in hydration is further
supported by the gain in entropy (Table 1) that most likely
results from water and counterion release during binding.
These hydrophobic interactions might explain why these two
monovalent CPCs bind the GAG in contrast to monovalent
arginine. In support, it has been found that soluble acridine
orange AOR can self-assemble when interacting with anionic
polyelectrolytes or interfaces (33,43,44). It may be noted that
the release of solvent water also plays a key role in binding
and aggregation of polycations with other polyelectrolytes
such as DNA (45–47).
Binding speciﬁcity
Despite larger differences in their primary structure, all CPCs
were found to bind with high afﬁnity to the GAG. It is
therefore suggested that GAG binding requires a speciﬁc
charge density of the CPC and neglects larger differences in
their overall structure. This structural ﬂexibility is further
supported by the ﬁnding that D-isomers and retro-inverso
sequences of CPPs also bind GAGs (48) and are efﬁciently
taken up by living cells (31,49–51).
It is of interest whether a comparable structural ﬂexibility is
also allowed for GAGs, or whether the CPP binding requires
TABLE 1 Binding of heparin to diverse CPCs
ITC DLS
Ligand and charge
(zCPC) at given pH* Kd,i (nM)
y
n binding sites
per heparinz
(nligands/nheparin) n 3 zCPC Kd,1 (nM)
§
Reaction enthalpy
DH0CPC
(kcal/mol CPC)
Entropy TDS0CPC
(kcal /mol CPC)
Heat capacity
change{ DC0PCPC
(cal/mol CPC/K) Rh** (nm)
FWHMyy of
Rh (nm)
HIV Tat-PTD81 443 6 178 6.68 6 0.57 53.4 6 4.55 67.9 6 30.5 –12.3 6 0.33 –3.47 6 0.37 38.6 94.4 6 5.9 36.1 6 6.6
Penetratin71 338 6 105 6.79 6 0.45 47.5 6 3.18 50.6 6 19.0 –11.6 6 0.12 –2.63 6 0.18 –128 129 6 18.7 51.1 6 8.4
Nona-L-arginine91 459 6 115 5.38 6 0.62 48.4 6 5.54 87.9 6 33.3 –12.8 6 2.65 –4.02 6 2.80 89.3 98.3 6 6.2 36.4 6 5.2
PLL16161 543 6 253 2.91 6 0.30 46.6 6 4.86 198 6 108 –8.50 6 0.11 0.18 6 0.30 11.0 77.7 6 6.8 24.8 6 6.9
LPEI201 (2.5 kDa);
pH 7.4
741 6 104 3.36 6 0.51 67.3 6 10.2 224 6 52.1 –16.5 6 2.12 –8.08 6 2.20 –235 131 6 14.1 28.9 6 7.2
LPEI581 (2.5 kDa);
pH 5.0
531 6 221 1.10 6 0.27 64.0 6 15.9 467 6 94.9 –37.1 6 4.98 –28.4 6 4.1 –76.1 123 6 12.2 38.1 6 4.1
DOTAP11 (as 30-nm
small unilamellar
vesicles; nDOTAP:
nDOPC ¼ 3:7)
1345 6 417 31.5 6 3.09 31.5 6 3.09 45.7 6 19.0 –0.49 6 0.07 7.82 6 0.53 –25.7 586 6 149 428 6 136
Acridine orange11 868 6 293 65.7 6 6.8 65.7 6 6.8 13.3 6 4.6 –3.82 6 0.27 4.59 6 0.48 –32.0 311 6 56.7 234 6 92.5
Ethidium bromide11 No binding observedzz ,10
Propidium iodide21 No binding observed ,10
L-arginine11 No binding observed ,10
*Conditions and pH (7.4) as described in Fig. 2; LPEI was measured additionally at pH 5.00 (133 mM NaCl, 30 mM acetate). Results are reported as mean6
SD from four individual sample preparations.
yMicroscopic dissociation constant (Kd,i) of n individual binding sites found per heparin chain.
zStoichiometry as experimentally determined (ITC) for 100% of heparin’s multiple binding sites saturated with the speciﬁc ligand; heparin had a sulfur
content of 11.3%, yielding an average of 45.8 sulfate groups or a total of 68.2 negative charges (including carboxyl groups) per heparin (average mol wt
13,000).
§Macroscopic dissociation constant (Kd,1) for the ﬁrst accessible binding site in the GAG.
{Molar heat capacity change at constant pressure (DC0P) as calculated from the slope of DH
0
CPC as a function of different temperatures (8, 18, 28, 38, 48, and
58C).
**Hydrodynamic radius (Rh) as experimentally determined for 50% of heparin’s binding sites (13.7 mM, 1.4 ml) saturated with the ligand; except for AOR
and DOTAP, which were measured at 10% and 5% saturation of heparin, respectively, because at higher molar ratios, Rh exceeded the laser’s wavelength. At
current settings, the lower detection limit was ;10 nm.
yyWidth of the Rh distribution was calculated as full width at half-maximum (FWHM).
zzPhysiological ionic strength apparently prevents binding of ethidium bromide to heparin (32).
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a speciﬁc GAG structure that could be exploited for organ-
speciﬁc targeting. Such speciﬁc GAG epitopes have been
postulated but then revised for GAG-mediated growth-factor
uptake (52). Likewise, recent studies demonstrated that a given
CPP binds to a variety of different GAG types with the binding
constant increasing as a function of the sulfate density (15) and
chain length of the GAG (30). As a result, a lyase speciﬁc for a
particular GAG type may be inefﬁcient to completely abolish
the CPC binding to GAGs in living cells, which previously led
to discussions on whether or not the GAG subtype heparan
sulfate is the only mediator of CPP uptake (1). The resulting
high structural ﬂexibility in the CPP-GAG interaction com-
binedwith the highbinding afﬁnity in the submicromolar range
might thus explain why CPPs are efﬁciently internalized by
many different cell strains (53), taking into account that GAGs
are ubiquitously expressed in vertebrates and invertebrates, in
contrast to speciﬁc receptor proteins.
Stoichiometry
The stoichiometry of the binding reactions corresponds ap-
proximately to charge neutralization (Table 1) with small
deviations related to steric constraints. Small molecules such
as AOR apparently adapt best to the heterogeneous anion
distance in GAGs and thus encounter the greatest number of
binding sites; in contrast, large molecules such as 30-nm
DOTAP vesicles are less ﬂexible and have the fewest binding
sites. For LPEI, the stoichiometry is additionally affected by
the pH because of its lower pKa (;7) (54) compared with
other CPCs that are maximally charged at physiological pH
(quaternary ions or pKa . 10). As a result, cell-internal pH
shifts as encountered during endosome acidiﬁcation might
affect the stoichiometry (Fig. 3) and tightness (Table 1) of the
LPEI binding.
GAG clustering
CPPs differ considerably in their primary structure and
physicochemical properties, suggesting that a unique con-
formation of the CPP is unlikely for binding to the biological
cell surface receptor. Such interactions of maximized geo-
metrical ﬁt (55) would be stereospeciﬁc because of their
natural content of L-isomeric amino acids. In contrast, en-
docytotic receptors react with a wider range of possible li-
gands (56) where the ligand binding may lead to clustering or
capping of integral membrane constituents, such as GAG-
containing proteoglycans (6–12) or N-linked GAGs (e.g.,
sialic acid type) (57,58). Such interactions affect the mem-
brane curvature (59), lateral diffusion (8), and clustering
(3,6–11) of their membrane anchor, cytoskeleton bundling
(3,7,9,14), and activation of intracellular protein kinases
(3,60–63), which are all considered crucial elements in recent
views of endocytosis (56). We therefore were interested in
whether CPCs not only bind GAGs, reﬂecting merely ad-
sorption to the cell surface, but also induce the clustering of
GAGs with consequences for endocytotic signals.
We ﬁnd that all CPCs, on GAG binding, produce particles
of considerable size as evident from the pronounced increase
in light scattering in titration experiments (Fig. 3). The radius
of the particles is 70 nm and larger (Fig. 4; Table 1), sug-
gesting that these clusters consist of several GAG chains
cross-linked by CPCs rather than of a single GAG chain
saturated with themaximum number of ligands (Table 1). The
maximum number of heparin molecules per cluster was
estimated by dividing the hydrodynamic volume of the par-
ticles by the volume of a single heparin chain saturated with
the known number of ligands (Table 1). The solvent-excluded
volumes of HIV-1 Tat (47–57) and heparin (dp44) employed
in this study are 1344 and 7863 A˚3, respectively, based on
their published structures in the protein database (1TAC and
FIGURE 3 GAG clustering upon CPC binding. Various cell-impermeant and
-permeant compounds are titrated into heparin solution (except control (4b),
into pure buffer), and the static right-angle light scattering (lex/lem¼ 350/350
nm) is recorded. The increase in light-scattering signal demonstrates the
formation of larger aggregates of CPCs and GAGs. No comparable scattering
signal is produced by the titration of GAGs with structurally related but cell-
impermeant compounds 6, 9, and 10. The heparin concentration in the optical
cuvette (Vcell ¼ 1.4 ml) is 13.7 mM. Each step corresponds to the injection of
10 ml (every 5 min) of the following compounds: (6) 5.2 mM propidium
iodide; (9) 10.4 mM L-arginine; (10) 5.2 mM ethidium bromide; (5) 5.2 mM
acridine orange; (8) 1.5 mM penetratin; (4) DOTAP vesicles ([DOTAP]out ¼
4.8 mM, 30 nm, DOTAP:DOPC¼ 3:7 (n/n)) into (4a) heparin or (4b) buffer;
(2) 650 mM PLL16; (3a–c) 359 mM linear polyethylenimine at (3a) pH 7.4,
(3b) pH 5.0, and (3c) pH 3.5; (7) 1.3 mMHIVTat-PTD; and (1) 1.1 mM nona-
L-arginine. Same absolute scale in both panels. Temperature is 28C. Buffer in
all experiments is 30 mM phosphate and 77 mM NaCl at pH 7.40 (ionic
strength of 154 mM); except LPEI (3b) at pH 5.0 using 30 mM acetate and
133 mM NaCl (ionic strength of 154 mM), and (3c) at pH 3.5 using 30 mM
formate and 141 mM NaCl (ionic strength of 154 mM).
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1hpn (1C4, dp12), respectively). Accordingly, the observed
GAG-CPC cluster (Rh¼ 94.4 nm) comprises up to 2.13 105
heparin molecules (each complexed with six or seven Tat
molecules) depending on the actual state of hydration.
The current GAG clustering in vitro relates to the GAG
capping recently observed in vivo (2,3). The size of the capping
complexes and their visibility in living cells under the light
microscope (2) depend on various aspects such as the molar
ratio of the reactants (Fig. 3), the type of the CPC (Fig. 4), and
also the type and length of the GAG (15). In contrast, no GAG
clustering was observed for monomeric arginine, ethidium
bromide, and propidium iodide (Fig. 3 and 4), as they do not
bind the GAG at physiological ionic strength (Fig. 2). This
agrees with their lack of endocytotic uptake (17).
CONCLUSIONS
The results presented here reveal that GAG binding and GAG
clustering are common properties of many CPCs. This study
shows that CPCs of four chemically unrelated groups react in
a very similar fashion. The CPC-GAG interactions are char-
acterized by a high afﬁnity and display a deﬁned number of
binding sites. The interactions allow for a structural vari-
ability of both CPC and GAG provided a critical charge
density of the reactants is met. Although this study reports
ﬁndings in solution, it follows from cell culture work that
CPCs may lead to GAG clustering on the surface of bio-
logical cells during the CPC uptake (2,3). Also, GAG clus-
tering and subsequent cellular uptake was observed for
speciﬁc antibodies against GAGs (9,11). In terms of a
screening assay, clustering of GAGs might therefore be
helpful to identify new cell-penetrating compounds.
We are grateful to Dr. Corinne Vebert (Department of Chemistry) for her
precious advice on DLS. We also thank Therese Schulthess for excellent
technical assistance.
This work was supported by the Swiss National Science Foundation under
grant No. 3100-107793/1.
REFERENCES
1. Richard, J. P., K. Melikov, E. Vives, C. Ramos, B. Verbeure, M. J.
Gait, L. V. Chernomordik, and B. Lebleu. 2003. Cell-penetrating pep-
tides. A reevaluation of the mechanism of cellular uptake. J. Biol.
Chem. 278:585–590.
2. Ziegler, A., P. Nervi, M. Durrenberger, and J. Seelig. 2005. The
cationic cell-penetrating peptide CPP(TAT) derived from the HIV-1
protein TAT is rapidly transported into living ﬁbroblasts: optical, bio-
physical, and metabolic evidence. Biochemistry. 44:138–148.
3. Kopatz, I., J. S. Remy, and J. P. Behr. 2004. A model for non-viral
gene delivery: through syndecan adhesion molecules and powered by
actin. J. Gene Med. 6:769–776.
4. Rejman, J., A. Wagenaar, J. B. Engberts, and D. Hoekstra. 2004. Char-
acterization and transfection properties of lipoplexes stabilized with
novel exchangeable polyethylene glycol-lipid conjugates. Biochim.
Biophys. Acta. 1660:41–52.
5. Wiethoff, C. M., J. G. Smith, G. S. Koe, and C. R. Middaugh. 2001.
The potential role of proteoglycans in cationic lipid-mediated gene
delivery. Studies of the interaction of cationic lipid-DNA complexes
with model glycosaminoglycans. J. Biol. Chem. 276:32806–32813.
6. Belting, M. 2003. Heparan sulfate proteoglycan as a plasma membrane
carrier. Trends Biochem. Sci. 28:145–151.
7. Dull, R. O., R. Dinavahi, L. Schwartz, D. E. Humphries, D. Berry, R.
Sasisekharan, and J. G. Garcia. 2003. Lung endothelial heparan sulfates
mediate cationic peptide-induced barrier dysfunction: a new role for the
glycocalyx. Am. J. Physiol. Lung Cell. Mol. Physiol. 285:L986–L995.
8. Fuki, I. V., M. E. Meyer, and K. J. Williams. 2000. Transmembrane
and cytoplasmic domains of syndecan mediate a multi-step endocytic
pathway involving detergent-insoluble membrane rafts. Biochem. J.
351:607–612.
9. Martinho, R. G., S. Castel, J. Urena, M. Fernandez-Borja, R. Makiya,
G. Olivecrona, M. Reina, A. Alonso, and S. Vilaro. 1996. Ligand
binding to heparan sulfate proteoglycans induces their aggregation and
distribution along actin cytoskeleton. Mol. Biol. Cell. 7:1771–1788.
10. Summerford, C., and R. J. Samulski. 1998. Membrane-associated
heparan sulfate proteoglycan is a receptor for adeno-associated virus
type 2 virions. J. Virol. 72:1438–1445.
11. Tkachenko, E., and M. Simons. 2002. Clustering induces redistribution
of syndecan-4 core protein into raft membrane domains. J. Biol. Chem.
277:19946–19951.
12. Tyagi, M., M. Rusnati, M. Presta, and M. Giacca. 2001. Internalization
of HIV-1 tat requires cell surface heparan sulfate proteoglycans. J. Biol.
Chem. 276:3254–3261.
13. Fischer, R., M. Fotin-Mleczek, H. Hufnagel, and R. Brock. 2005.
Break on through to the other side-biophysics and cell biology shed
light on cell-penetrating peptides. ChemBioChem. 6:2126–2142.
14. Nakase, I., A. Tadokoro, N. Kawabata, T. Takeuchi, H. Katoh, K.
Hiramoto, M. Negishi, M. Nomizu, Y. Sugiura, and S. Futaki. 2007.
Interaction of arginine-rich peptides with membrane-associated prote-
oglycans is crucial for induction of actin organization and macro-
pinocytosis. Biochemistry. 46:492–501.
FIGURE 4 Conﬁrmation of the GAG clustering caused by CPCs. DLS
intensity autocorrelation functions were recorded at eight different angles
(30–150). Displayed are recordings at u ¼ 90 for 50% of heparin’s
(13.7 mM, 1.4 ml) sulfate charges saturated with indicated cationic com-
pounds. Recordings for AOR (ethidium bromide and propidium iodide) and
DOTAP are displayed for 10% and 5% charge saturation of heparin,
respectively, so that the particle size did not exceed the sensitive range of
the instrument (,1 mm). All CPCs caused a clustering of GAGs as evident
from the complex size of.70 nm (Table 1), which is considerably larger than
a single GAG molecule saturated with the deﬁned number of CPCs. In
contrast, virtually no light scattering was found for the structurally related but
non-cell-permeant compounds 10, 9, and 6 even when a 16-times higher
receiver gain was used than for the other compounds. Individual tracings are
(10) ethidium bromide, (9) L-arginine, (6) propidium iodide, (2) PLL16, (7)
HIV Tat-PTD, (1) nona-L-arginine, (3) polyethylenimine, (8) penetratin, (5)
acridine orange, and (4) DOTAP vesicles ([DOTAP]out ¼ 4.8 mM, 30 nm,
DOTAP:DOPC¼ 3:7 (n/n)). Temperature was 20C. Buffer in all experiments
is 30 mM phosphate and 77 mMNaCl at pH 7.40 (ionic strength of 154 mM).
Glycosaminoglycan Binding and Clustering 2147
Biophysical Journal 94(6) 2142–2149
15. Ziegler, A., and J. Seelig. 2004. Interaction of the protein transduction
domain of HIV-1 TAT with heparan sulfate: binding mechanism and
thermodynamic parameters. Biophys. J. 86:254–263.
16. Ziegler, A., and J. Seelig. 2007. High afﬁnity of the cell-penetrating
peptide HIV-1 Tat-PTD for DNA. Biochemistry. 46:8138–8145.
17. Bank, H. L. 1987. Assessment of islet cell viability using ﬂuorescent
dyes. Diabetologia. 30:812–816.
18. Sugar, J., and E. Gati. 1958. Change of acridine orange uptake by cells
of Ehrlich ascites tumors under the effect of different chemotherapeutic
agents. Krebsarzt. 13:119–120.
19. Andrade, S. M., and S. M. Costa. 2002. The aqueous environment in
AOT and Triton X-100 (w/o) microemulsions probed by ﬂuorescence.
Photochem. Photobiol. Sci. 1:500–506.
20. Dell’Antone, P., and G. F. Azzone. 1974. Inhibition of energy-linked
uptake of acridine dyes by permeant anions. FEBS Lett. 39:67–72.
21. Haran, G., R. Cohen, L. K. Bar, and Y. Barenholz. 1993. Transmem-
brane ammonium sulfate gradients in liposomes produce efﬁcient and
stable entrapment of amphipathic weak bases. Biochim. Biophys. Acta.
1151:201–215.
22. Wirth, M. J., and J. D. Burbage. 1991. Adsorbate reorientation at a
water/(octadecylsilyl)silica interface. Anal. Chem. 63:1311–1317.
23. Mulloy, B., and R. J. Linhardt. 2001. Order out of complexity–protein
structures that interact with heparin. Curr. Opin. Struct. Biol. 11:623–628.
24. van Holde, K. E., W. C. Johnson, and P. S. Ho. 1998. Chemical
equilibria involving macromolecules. In Principles of Physical Bio-
chemistry. K. E. van Holde, W. C. Johnson, and P. S. Ho, editors.
Prentice Hall, Upper Saddle River, NJ. 604–611.
25. Koppel, D. E. 1972. Analysis of macromolecular polydispersity in
intensity correlation spectroscopy: The method of cumulants. J. Chem.
Phys. 57:4814–4820.
26. Connolly, M. L. 1993. The molecular surface package. J. Mol. Graph.
11:139–141.
27. Schafer, I. A., J. C. Sullivan, J. Svejcar, J. Kofoed, and W. V.
Robertson. 1968. Study of the Hurler syndrome using cell culture:
deﬁnition of the biochemical phenotype and the effects of ascorbic acid
on the mutant cell. J. Clin. Invest. 47:321–328.
28. Turnbull, J. E., and J. T. Gallagher. 1991. Sequence analysis of heparan
sulphate indicates deﬁned location of N-sulphated glucosamine and
iduronate 2-sulphate residues proximal to the protein-linkage region.
Biochem. J. 277:297–303.
29. Goncalves, E., E. Kitas, and J. Seelig. 2005. Binding of oligoarginine
to membrane lipids and heparan sulfate: structural and thermodynamic
characterization of a cell-penetrating peptide. Biochemistry. 44:2692–
2702.
30. Rusnati, M., G. Tulipano, D. Spillmann, E. Tanghetti, P. Oreste, G.
Zoppetti, M. Giacca, and M. Presta. 1999. Multiple interactions of
HIV-I Tat protein with size-deﬁned heparin oligosaccharides. J. Biol.
Chem. 274:28198–28205.
31. Brugidou, J., C. Legrand, J. Mery, and A. Rabie. 1995. The retro-
inverso form of a homeobox-derived short peptide is rapidly internal-
ised by cultured neurones: a new basis for an efﬁcient intracellular
delivery system. Biochem. Biophys. Res. Commun. 214:685–693.
32. Chaudhuri, S., G. O. Phillips, D. M. Power, and J. V. Davies. 1975.
Interaction of ethidium bromide with heparin. Int. J. Radiat. Biol.
Relat. Stud. Phys. Chem. Med. 28:345–352.
33. Menter, J. M., R. E. Hurst, N. Nakamura, and S. S. West. 1979.
Thermodynamics of mucopolysaccharide-dye binding. III. Thermody-
namic and cooperativity parameters of acridine orange-heparin system.
Biopolymers. 18:493–505.
34. Beisker, W., and W. G. Eisert. 1989. Denaturation and condensation
of intracellular nucleic acids monitored by ﬂuorescence depolarization
of intercalating dyes in individual cells. J. Histochem. Cytochem. 37:
1699–1704.
35. Giancotti, V., F. Quadrifoglio, and V. Crescenzi. 1973. Polyelectrolyte
behaviour of phosvitin. Spectroscopic, microcalorimetric and acridine-
orange-binding data. Eur. J. Biochem. 35:78–86.
36. Matteoni, R., and T. E. Kreis. 1987. Translocation and clustering of
endosomes and lysosomes depends on microtubules. J. Cell Biol. 105:
1253–1265.
37. Rouzina, I., and V. A. Bloomﬁeld. 1996. Macroion attraction due
to electrostatic correlation between screening counterions. 1. Mobile
surface-adsorbed ions and diffuse ion cloud. J. Phys. Chem. 100:9977–
9989.
38. Tanford, C. 1979. Interfacial free energy and the hydrophobic effect.
Proc. Natl. Acad. Sci. USA. 76:4175–4176.
39. Sturtevant, J. M. 1977. Heat capacity and entropy changes in processes
involving proteins. Proc. Natl. Acad. Sci. USA. 74:2236–2240.
40. Hileman, R. E., R. N. Jennings, and R. J. Linhardt. 1998. Thermody-
namic analysis of the heparin interaction with a basic cyclic peptide
using isothermal titration calorimetry. Biochemistry. 37:15231–15237.
41. Thompson, L. D., M. W. Pantoliano, and B. A. Springer. 1994.
Energetic characterization of the basic ﬁbroblast growth factor-heparin
interaction: identiﬁcation of the heparin binding domain. Biochemistry.
33:3831–3840.
42. Sakai, N., and S. Matile. 2003. Anion-mediated transfer of polyargi-
nine across liquid and bilayer membranes. J. Am. Chem. Soc. 125:
14348–14356.
43. Myhr, B. C., and J. G. Foss. 1971. Acridine orange-poly(alpha-L-
glutamic acid) complexes. I. Stoichiometry and stacking coefﬁcients.
Biopolymers. 10:425–440.
44. Yao, H., S. Kobayashi, and K. Kimura. 2007. Self-assembly of acridine
orange dye at a mica/solution interface: formation of nanostripe
supramolecular architectures. J. Colloid Interface Sci. 307:272–279.
45. Zhang, W., J. P. Bond, C. F. Anderson, T. M. Lohman, and M. T.
Record, Jr. 1996. Large electrostatic differences in the binding ther-
modynamics of a cationic peptide to oligomeric and polymeric DNA.
Proc. Natl. Acad. Sci. USA. 93:2511–2516.
46. Jonsson, M., and P. Linse. 2003. Monte Carlo simulations of the
hydrophobic effect in aqueous electrolyte solutions. J. Phys. Chem. B.
115:3406–3418.
47. Patel, M. M., and T. J. Anchordoquy. 2005. Contribution of hydro-
phobicity to thermodynamics of ligand-DNA binding and DNA col-
lapse. Biophys. J. 88:2089–2103.
48. Goncalves, E., E. Kitas, and J. Seelig. 2006. Structural and thermody-
namic aspects of the interaction between heparan sulfate and analogues
of melittin. Biochemistry. 45:3086–3094.
49. Gammon, S. T., V. M. Villalobos, J. L. Prior, V. Sharma, and D.
Piwnica-Worms. 2003. Quantitative analysis of permeation peptide
complexes labeled with Technetium-99m: chiral and sequence-speciﬁc
effects on net cell uptake. Bioconjug. Chem. 14:368–376.
50. Shen, W. C., and H. J. Ryser. 1979. Poly (L-lysine) and poly (D-lysine)
conjugates of methotrexate: different inhibitory effect on drug resistant
cells. Mol. Pharmacol. 16:614–622.
51. Wender, P. A., D. J. Mitchell, K. Pattabiraman, E. T. Pelkey, L.
Steinman, and J. B. Rothbard. 2000. The design, synthesis, and
evaluation of molecules that enable or enhance cellular uptake: peptoid
molecular transporters. Proc. Natl. Acad. Sci. USA. 97:13003–13008.
52. Kreuger, J., P. Jemth, E. Sanders-Lindberg, L. Eliahu, D. Ron, C.
Basilico, M. Salmivirta, and U. Lindahl. 2005. Fibroblast growth fac-
tors share binding sites in heparan sulphate. Biochem. J. 389:145–150.
53. Mann, D. A., and A. D. Frankel. 1991. Endocytosis and targeting of
exogenous HIV-1 Tat protein. EMBO J. 10:1733–1739.
54. Smits, R. G., G. J. M. Koper, and M. Mandel. 1993. The inﬂuence of
nearest- and next-nearest-neighbor interactions on the potentiometric
titration of linear poly(ethylenimine). J. Phys. Chem. 97:5745–5751.
55. Cramer, F. 1995. Biochemical correctness: Emil Fischer’s lock and
key hypothesis, a hundred years after—an essay. Pharm. Acta. Helv.
69:193–203.
56. Herz, J., and D. K. Strickland. 2001. LRP: a multifunctional scavenger
and signaling receptor. J. Clin. Invest. 108:779–784.
57. Freeze, H. H., and A. Varki. 1986. Endo-glycosidase F and peptide
N-glycosidase F release the great majority of total cellular N-linked
2148 Ziegler and Seelig
Biophysical Journal 94(6) 2142–2149
oligosaccharides: use in demonstrating that sulfated N-linked oligo-
saccharides are frequently found in cultured cells. Biochem. Biophys.
Res. Commun. 140:967–973.
58. Roux, L., S. Holojda, G. Sundblad, H. H. Freeze, and A. Varki. 1988.
Sulfated N-linked oligosaccharides in mammalian cells. I. Complex-
type chains with sialic acids and O-sulfate esters. J. Biol. Chem. 263:
8879–8889.
59. McMahon, H. T., and J. L. Gallop. 2005. Membrane curvature and mech-
anisms of dynamic cell membrane remodelling. Nature. 438:590–596.
60. Biener, Y., and Y. Zick. 1990. Basic polycations activate the insulin
receptor kinase and a tightly associated serine kinase. Eur. J. Biochem.
194:243–250.
61. Khan, N. A., I. Masson, V. Quemener, G. Clari, V. Moret, and J. P.
Moulinoux. 1990. Polyamines and polyamino acids regulation of
cytosolic tyrosine protein (Tyr-P) kinase from human erythrocytes.
Biochem. Int. 20:863–868.
62. Mohammadi, M., A. Honegger, A. Sorokin, A. Ullrich, J. Schlessinger,
and D. R. Hurwitz. 1993. Aggregation-induced activation of the epider-
mal growth factor receptor protein tyrosine kinase. Biochemistry. 32:
8742–8748.
63. Xu, Q. Y., S. L. Li, T. R. LeBon, and Y. Fujita-Yamaguchi. 1991.
Aggregation of IGF-I receptors or insulin receptors and activation of
their kinase activity are simultaneously caused by the presence of
polycations or K-ras basic peptides. Biochemistry. 30:11811–11819.
Glycosaminoglycan Binding and Clustering 2149
Biophysical Journal 94(6) 2142–2149
